Cargando…
Second-Line Treatment Options for Hepatocellular Carcinoma: Current Landscape and Future Direction
Hepatocellular carcinoma is a leading cause of mortality worldwide, and its incidence is rising. The last few years have witnessed a proliferation of available systemic therapeutic options, with the approval of multiple agents, including immune checkpoint inhibitors and drugs targeting vascular endo...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464222/ https://www.ncbi.nlm.nih.gov/pubmed/34584898 http://dx.doi.org/10.2147/JHC.S268314 |